The effect of high dose simvastatin on, platelet size in patients with, type 2 diabetes mellitus

William L. Isley, Youngsoon Park, William S. Harris

Research output: Contribution to journalArticle

1 Scopus citations


Statins reduce coronary heart disease risk by altering blood lipids and other mechanisms. One of the possible other mechanisms is through an effect on thrombosis. We assessed the effect of simvastatin 80 mg daily versus placebo given in a single blind crossover fashion on platelet size in response to standard ex vivo stimuli, a surrogate for platelet activation, in 12 subjects with type 2 diabetes and mixed dyslipidemia. Exposure to collagen, cold, and heat caused the expected changes in platelet volume. Contrary to our expectations, ex vivo platelet size during collagen and cold exposure increased by 2.6 and 1.7%, respectively (P < 0.05), during simvastatin treatment as opposed to the placebo period. We conclude that some of the effects of high dose simvastatin therapy on platelets may not necessarily be anti-atherogenic.

Original languageEnglish (US)
Pages (from-to)292-295
Number of pages4
Issue number5
StatePublished - Aug 1 2006



  • Coagulation
  • Platelets
  • Simvastatin
  • Type 2 diabetes

ASJC Scopus subject areas

  • Hematology

Cite this